BSE filing, NSE: SWIGGY. Summary written from the filing by ALFA Finder's alert engine.
Swiggy Ltd: key numbers
- Share price
- ₹183.50
- Market cap
- ₹50,652 Cr
- Revenue (annual)
- ₹23,053 Cr
- Net profit (annual)
- ₹-4,154 Cr
- P/E (TTM)
- -14.2×Sector 62.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 8.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Swiggy Ltd
All →Swiggy Capital Structure Change
Nippon India Mutual Fund bought about 0.18% of Swiggy, lifting its stake from 4.99% to 5.17%. The disclosure is a non-promoter Reg 29(1) filing covering open-market purchases through October 26, 2026.
- Execution
- Purchase transactions from November 13, 2024 to October 26, 2026
Swiggy Annual General Meeting
Swiggy's postal ballot seeks shareholder approval to re-appoint two independent directors, Anand Kripalu and Suparna Mitra. E-voting runs until 27 Nov 2026.
Swiggy Other Announcement
Swiggy Limited submitted the Monitoring Agency Report for the quarter ended September 30, 2026, regarding the utilization of IPO and QIP proceeds.
Swiggy Earnings Call Transcript: Key Takeaways
Swiggy is pivoting back to growth, leveraging 'Toing' for affordable food delivery to expand the market while Instamart focuses on high-frequency habit building.
- Call
- Guides 20% growth
Swiggy Results Update
Swiggy's Q2 FY27 letter reports B2C GOV of ₹20,793 Cr and Adjusted Revenue of ₹7,909 Cr. Food delivery EBITDA reached a record ₹341 Cr at 3.4% margin.
Swiggy Management Change
Swiggy's board approved re-appointment of Anand Kripalu and Suparna Mitra as Non-Executive Independent Directors for five-year terms. Both appointments are subject to shareholder approval.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.